How would you approach a patient with vitreoretinal lymphoma without CNS or systemic involvement?

The optimal treatment approach for primary intraocular lymphoma is debated. This is a rare disease with only small retrospective series guiding therapy. There is no clear superior treatment approach in the literature. In clinical practice, younger patients are often treated initially with high-dose ...

I always learn from Dr. @Dr. First Last! We have a similar approach here at UCSD. Majority of our patients with this disease have been older (> 60). For unilateral primary intraocular lymphoma, we start with intra-ocular Rituximab. If inadequate response, we treat with ISRT to 36 Gy. We delay system...